SARS-CoV-2-IN-39

CAS No. 2882823-03-0

SARS-CoV-2-IN-39( —— )

Catalog No. M36928 CAS No. 2882823-03-0

SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 Get Quote
5MG 113 Get Quote
10MG 166 Get Quote
25MG 271 Get Quote
50MG 408 Get Quote
100MG 588 Get Quote
500MG 1215 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SARS-CoV-2-IN-39
  • Note
    Research use only, not for human use.
  • Brief Description
    SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
  • Description
    SARS-CoV-2-IN-39 (compound 21) is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 against SARS-CoV-2 by inhibiting of SKP2 protein and stabilizing BECN1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    SARS-CoV | Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2882823-03-0
  • Formula Weight
    349.66
  • Molecular Formula
    C14H8ClF4NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1=CC=C(OC(F)(F)F)C=C1)(=O)C2=C(O)C=C(F)C(Cl)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rui Li, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. ?
molnova catalog
related products
  • CMX-521

    CMX-521 has antiviral activity, inhibits oronavirus activity, and can be used in the study of viral infections.

  • LCC-12 FA

    LCC-12 FA is a dimer composed of metformin that induces a decrease in the NAD(H) pool by targeting mitochondrial copper(ii).

  • 5-Fluorocytidine

    5-Fluorocytidine with antiviral activity.